Takeda (NYSE:TAK) announced Phase 3 LATITUDE study results for investigational drug zasocitinib (TAK-279), reporting statistically significant improvements compared with deucravacitinib in adults with moderate-to-severe plaque psoriasis.
AbbVie (NYSE:ABBV) announced that it will present 60 dermatology research abstracts, including three late-breaking presentations, at the 2026 European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria, covering multiple immune-mediated skin diseases.
Amentum (NYSE:AMTM) has been selected by United Kingdom nuclear site operator Sellafield as preferred supplier for a Projects and Asset Care Execution (PACE) framework contract valued at up to £2.1 billion ($2.78 billion).
AbbVie (NYSE:ABBV) reported positive Phase 2 APEX Part B study results for zumilokibart, with all three tested dose regimens achieving the primary endpoint among 346 adults with moderate to severe atopic dermatitis.
Kalshi is in advanced talks to raise about $1 billion at a $40 billion valuation, according to an exclusive Reuters report.
New South Wales Senator David Shoebridge has been elected as the new leader of the Australian Greens.
Robinhood Markets Inc (NASDAQ:HOOD) has unveiled AI trading agents and crypto perpetual futures for eligible US customers.
Delta Lithium (ASX:DLI) has announced planned drill testing on six new reconnaissance targets at its Yinnetharra Project.
Yancoal Australia (ASX:YAL) has secured state planning approval to continue operations at its Hunter Valley complex until 2045.
CSD BR has begun mirroring Banco BTG Pactual (B3:BPAC11) fund shares on the XRP Ledger.
GARANTA JÁ SEU GRAFA EDGE
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
